Andrew Y. Yan - 18 Mar 2026 Form 3 Insider Report for SINOVAC BIOTECH LTD (SVA)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
18 Mar 2026, 08:06:35 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Andrew Y. Yan

Key filing fact

Andrew Y. Yan filed Form 3 for SINOVAC BIOTECH LTD (SVA) on 18 Mar 2026.

Key facts

  • This page summarizes Andrew Y. Yan's Form 3 filing for SINOVAC BIOTECH LTD (SVA).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 18 Mar 2026, 08:06.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001305509 Primary reporting owner

Yan Andrew Y

Relationship
Director
Address
SUITE 1102, 11/F, FIVE PACIFIC PLACE, 28 HENNESSY ROAD, WANCHAI, HONG KONG, CHINA
Signature
/s/ Andrew Y. Yan
Signature date
18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SVA holding

Common shares, par value $0.001 per share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
10,780,820
Date
18 Mar 2026
Ownership
By SAIF Partners IV L.P.
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

a. The Reporting Person is a director and sole shareholder of SAIF IV GP Capital Ltd., which is the sole general partner of SAIF IV GP, L.P., the sole general partner of SAIF Partners IV L.P. b. The Reporting Person may be deemed to beneficially own all the common shares, par value $0.001 per share, of the Issuer held by SAIF Partners IV L.P. c. The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .